Akèy › Dyabèt tip 1 › Indiana › Indianapolis
Etid klinik pou Dyabèt tip 1 nan Indianapolis, IN
14 etid pou Dyabèt tip 1 ap chèche patisipan nan sit nan ak bò kote Indianapolis (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Finding Immune Nascent Type 1 Diabetes
Ap rekriteVolontè an sante akeyi
- Indiana University School of Medicine, Indianapolis
App-Based Certified Diabetes Education Therapy (AB-CDE)
Ap rekrite
- Indiana University, Indianapolis
Type 1 Diabetes Extension Study
Ap rekriteEtid obsèvasyon
- Indiana University Riley Hospital for Children, Indianapolis
CNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)
Ap rekriteFaz 1/2
- Riley Hospital for Children- Indiana University, Indianapolis
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
Ap rekriteFaz 2
- Indiana University-Riley Hospital for Children, Indianapolis
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 Diabetes
Ap rekriteFaz 1/2
- Indiana University, Indianapolis
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Progression of Type 1 Diabetes
Ap rekriteFaz 2
- IUH - Riley Hospital for Children - Riley Outpatient Center - Pediatric Diabetes & Endocrinology, Indianapolis
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
Ap rekriteFaz 2
- Indiana University School of Medicine, Indianapolis
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
Ap rekriteFaz 2
- Indiana University, Indianapolis
Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
Ap rekrite
- Indiana University, Indianapolis
Denosumab for Type 1 Diabetes
Ap rekriteFaz 1/2
- Indiana University, Indianapolis
Registry for Stage 2 Type 1 Diabetes
Ap rekriteEtid obsèvasyon
- Indiana University Health Riley Hospital for Children- Site Number : 8400004, Indianapolis
To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.
Ap rekrite
- Indiana University Health, Univeristy hospital, Indianapolis
TrialNet Pathway to Prevention of T1D
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- Riley Hospital for Children, Indiana University, Indianapolis
Etid Dyabèt tip 1 nan lòt vil
- Aurora, CO23 etid
- Boston, MA21 etid
- Seattle, WA18 etid
- Chicago, IL16 etid
- New Haven, CT15 etid
- New York City, NY15 etid
- San Francisco, CA14 etid
- Miami, FL13 etid
- Gainesville, FL12 etid
- Philadelphia, PA11 etid
- Atlanta, GA11 etid
- Durham, NC10 etid
Lòt etid nan Indianapolis
- Kansè Poumon ki pa ti selil32 etid
- Kansè (tout kalite)24 etid
- Ensifizyans kadyak23 etid
- Kansè nan tete20 etid
- Obèsite20 etid
- Kansè Metastatik19 etid
- Kansè kolorektal18 etid
- Kansè ovè17 etid
- Kansè poumon16 etid
- Maladi kadyovaskilè16 etid
- Kansè Endomèt14 etid
- Maladi Alzheimer14 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.